These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15960286)

  • 41. Successful treatment of long-term, poststroke, upper-limb spasticity with onabotulinumtoxinA.
    Patel AT
    Phys Ther; 2011 Nov; 91(11):1636-41. PubMed ID: 21868610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of botulinum toxin in spasticity and headaches: a common key?
    Sandrini G
    Funct Neurol; 2008; 23(2):61. PubMed ID: 18671904
    [No Abstract]   [Full Text] [Related]  

  • 45. [Guide to the comprehensive treatment of spasticity].
    Vivancos-Matellano F; Pascual-Pascual SI; Nardi-Vilardaga J; Miquel-Rodriguez F; de Miguel-Leon I; Martinez-Garre MC; Martinez-Caballero I; Lanzas-Melendo G; Garreta-Figuera R; Garcia-Ruiz PJ; Garcia-Bach M; Garcia-Aymerich V; Bori-Fortuny I; Aguilar-Barbera M;
    Rev Neurol; 2007 Sep 16-30; 45(6):365-75. PubMed ID: 17899519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localized 100 Hz vibration improves function and reduces upper limb spasticity: a double-blind controlled study.
    Casale R; Damiani C; Maestri R; Fundarò C; Chimento P; Foti C
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):495-504. PubMed ID: 24651209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonsurgical Treatment Options for Upper Limb Spasticity.
    Black L; Gaebler-Spira D
    Hand Clin; 2018 Nov; 34(4):455-464. PubMed ID: 30286960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current spasticity management in children with spinal cord injury.
    Beck T
    SCI Nurs; 2002; 19(1):28-31. PubMed ID: 12510503
    [No Abstract]   [Full Text] [Related]  

  • 52. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke].
    Gekht AB; Burd GS; Selikhova MV; Iaish F; Beliakov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):22-9. PubMed ID: 9819884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
    Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE
    Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin for spasticity after stroke.
    Dobkin BH
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530439
    [No Abstract]   [Full Text] [Related]  

  • 59. Botulinum toxin for spasticity after stroke.
    Landau WM
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12529471
    [No Abstract]   [Full Text] [Related]  

  • 60. Sigma receptor modulation of the muscle relaxant action of eperisone.
    Hasegawa Y; Kaku S; Araki H; Otomo S
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.